{
  "id": "d272f0ffe725bd91",
  "title": "Zenas BioPharma Announces Late - Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026",
  "description": "20260209T124500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/09/tmt-newswire/globenewswire/zenas-biopharma-announces-late-breaking-platform-presentation-of-results-from-phase-2-moonstone-trial-of-obexelimab-in-relapsing-multiple-sclerosis-at-actrims-forum-2026/2274260",
  "published_at": "20260209T124500Z",
  "fetched_at": "2026-02-10T00:34:54.529614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/09/tmt-newswire/globenewswire/zenas-biopharma-announces-late-breaking-platform-presentation-of-results-from-phase-2-moonstone-trial-of-obexelimab-in-relapsing-multiple-sclerosis-at-actrims-forum-2026/2274260",
    "url_mobile": "https://www.manilatimes.net/2026/02/09/tmt-newswire/globenewswire/zenas-biopharma-announces-late-breaking-platform-presentation-of-results-from-phase-2-moonstone-trial-of-obexelimab-in-relapsing-multiple-sclerosis-at-actrims-forum-2026/2274260/amp",
    "title": "Zenas BioPharma Announces Late - Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026",
    "seendate": "20260209T124500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/09/930370.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}